The management of sickle cell pain.
Treatment of pain in the setting of sickle cell disease remains unsatisfactory. The approach remains to treat the pain symptomatically with escalating doses of non-opioid and opioid medications while any underlying inciting process is investigated. For the majority of patients with sickle cell disease, pain will always be part of their lives. Advances in the treatment of sickle cell pain will depend on multiple approaches, including both pharmacologic and nonpharmacologic.
Richard
Robert E
RE
Seattle Cancer Care Alliance, Adult Sickle Cell Clinic, Puget Sound Health Care System, Division of Hematology, University of Washington School of Medicine, Seattle, WA 98108, USA. rrichard@u.washington.edu
D000755:Anemia, Sickle Cell / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D000986:Antisickling Agents / Q000627:therapeutic use; D019468:Disease Management; D006801:Humans; D010146:Pain / Q000209:etiology* / Q000503:physiopathology; D059408:Pain Management
D000986:Antisickling Agents